Major Portfolio Expansion
Montanova Capital Invests Millions in Veradermics and Meme ETF Holdings
Anonymous
Key Points
1
Montanova Capital LLC owned about 0.34% of Roundhill Meme Stock ETF (MEME) at the end of the quarter, a detail not mentioned in the summary.
2
In Capricor Therapeutics (CAPR), Chief Financial Officer Anthony Bergmann sold 24,100 shares on June 25 at an average price of $30.38, a move that accompanies other insider selling and represents a 68.23% decrease in his position; insiders sold 25,000 CAPR shares in the last 90 days.
3
Veradermics (MANE) saw notable insider activity: Timothy August Durso sold 43,500 shares on August 17 at $107.82, and Director John W. Childs sold 100,000 shares on August 12; over the last 90 days insiders have sold about 961,000 MANE shares, while Bamco Inc. NY increased its MANE stake to 229,581 shares (+169,913).
4
At Centene (CNC), General Counsel Christopher Koster sold 56,500 shares on August 26, and after the sale he owned 248,854 shares valued at roughly $16.65 million, a notable insider move not captured in the summary.
Montanova Capital LLC made aggressive moves in the second quarter, deploying over $600 million across healthcare, materials, and meme-stock ETFs. The hedge fund's biggest bet was a $512.5 million position in Veradermics (MANE), making it the fund's second-largest holding at 8.5% of its portfolio Watchlist News. The firm also scooped up 603,000 shares of the Roundhill Meme Stock ETF (MEME) worth $26.8 million, signaling confidence in high-momentum plays.
But insider selling at several of Montanova's new positions raises red flags. At Veradermics alone, insiders dumped about 961,000 shares over 90 days, including a director who sold 100,000 shares on August 12 Ticker Report. At Capricor Therapeutics (CAPR), the CFO offloaded shares at $30.38 each, cutting his stake by 68%. The contrasting moves suggest Montanova sees opportunity where company insiders see exit signs.
Veradermics Bet Signals Major Portfolio Shift
Montanova's $512.5 million Veradermics investment dwarfs its other Q2 moves. The 4.17 million-share position represents 8.5% of the fund's total portfolio, making it the second-largest holding Watchlist News. Yet insider activity tells a different story. Timothy August Durso sold 43,500 shares on August 17 at $107.82 per share.
Director John W. Childs sold 100,000 shares on August 12. Combined with other insider sales, roughly 961,000 Veradermics shares hit the market in just 90 days Ticker Report. Bamco Inc. NY also increased its stake, adding 169,913 shares to reach 229,581 total. The insider selling pressure contradicts the institutional buying momentum.
Capricor and Centene Insider Pullbacks
Montanova boosted Capricor Therapeutics to over 4.09 million shares by adding 274,184 new ones Watchlist News. But CFO Anthony Bergmann sold 24,100 shares on June 25 at $30.38 each, slashing his position by 68.23%. Insiders overall sold 25,000 CAPR shares in the prior 90 days, suggesting leadership sees limited upside.
At Centene, General Counsel Christopher Koster sold 56,500 shares on August 26, retaining 248,854 shares worth roughly $16.65 million Ticker Report. The sale occurred shortly after Montanova initiated its 99,100-share position in the healthcare firm. Insider moves to reduce stakes often precede broader selloffs.
Meme ETF and Materials Play Round Out Portfolio
Montanova owns 0.34% of the Roundhill Meme Stock ETF, having bought 603,000 shares worth $26.8 million Watchlist News. The move reflects appetite for high-volatility, retail-driven equities. Meanwhile, the fund opened a 26,000-share position in Martin Marietta Materials (MLM) for approximately $15 million Ticker Report. Both trades suggest Montanova is chasing momentum across diverse asset classes.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
12
Articles
6
Reach
18
A
AnonymousAuthor
